Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
| AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
| SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2017-11-13 | 2017-11-27 | 29114 |
| SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2019-02-12 | 2020-10-27 | 75492 |
| SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2022-09-21 | 2022-10-20 | 169691 |
| SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2023-03-02 | 2023-06-06 | 186061 |
| SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2023-10-02 | 2024-02-01 | 205797 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |
| MYLAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2017-08-24 | 2017-10-03 | 20271 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |